Occupational exposure to benzene and risk of non‐ <scp>Hodgkin</scp> lymphoma in an extended follow‐up of two population‐based prospective cohorts of <scp>Chinese</scp> men and women
The carcinogenicity of benzene was reevaluated by the International Agency for Research on Cancer in 2017, with the Working Group reaffirming positive yet inconclusive associations with non-Hodgkin lymphoma (NHL). To extend our previous observation of a significant exposure-response for cumulative occupational benzene exposure and NHL risk among Chinese women in a population-based cohort in Shanghai, we extended follow-up of this cohort and pooled the data with a similarly designed population-based cohort of men in Shanghai. Cumulative exposure estimates were derived for 134,449 participants in the pooled analysis by combining ordinal job-exposure matrix intensity ratings with quantitative benzene measurements from an inspection database of Shanghai factories. Associations between benzene exposure metrics and NHL (n = 363 cases including multiple myeloma [MM]) were assessed using Cox proportional hazard models. Ever occupational exposure to benzene in the pooled population was associated with NHL risk (HR = 1.5, 95% CI = 1.2-2.0), and exposure-response relationships were observed for increasing duration (p<sub>trend</sub> = .003) and cumulative exposure (p<sub>trend</sub> = .003). Associations with ever exposure, duration, and cumulative exposure were similar for NHL with and without MM in the case definition, including lifetime cumulative exposures in the highest quartile (HR = 1.6, 95% CI = 1.1-2.4 with MM included; HR = 1.7, 95% CI = 1.1-2.7 with MM excluded). An elevated risk of the chronic lymphocytic leukemia subtype was suggested in the pooled analyses (HR for ever vs. never exposure = 2.3, 95% CI = 0.9-5.6). These observations provide additional support for a plausible association between occupational benzene exposure and risk of NHL.
Authors
- Bryan A. Bassig (ORCID: https://orcid.org/0000-0002-0278-8597)
- Mark P. Purdue (ORCID: https://orcid.org/0000-0003-1177-3108)
- Roel C.H. Vermeulen (ORCID: https://orcid.org/0000-0003-4082-8163)
- Gong Yang
- Bu‐Tian Ji (ORCID: https://orcid.org/0000-0002-8000-4997)
- Melissa C. Friesen (ORCID: https://orcid.org/0000-0002-1695-3282)
- Jason Y.Y. Wong (ORCID: https://orcid.org/0000-0003-2820-2133)
- Yu‐Tang Gao (ORCID: https://orcid.org/0000-0003-3904-1777)
- Xiao‐Ou Shu (ORCID: https://orcid.org/0000-0002-0711-8314)
- Wei Zheng (ORCID: https://orcid.org/0000-0003-1226-070X)
- Qing Lan (ORCID: https://orcid.org/0009-0007-3215-4652)
- Wei Hu (ORCID: https://orcid.org/0000-0002-3691-7545)
- Nathaniel Rothman
- Nathan M. Appel
Institutions
- Inova Health System (US)
- Utrecht University (NL)
- Vanderbilt University (US)
- National Heart, Lung, and Blood Institute (US)
- Shanghai Cancer Institute (CN)
- Information Management Services (US)
- National Cancer Institute (US)
- Division of Cancer Epidemiology and Genetics
Publication Details
- Journal
- International Journal of Cancer
- Published
- 2024-09-02
- DOI
- https://doi.org/10.1002/ijc.35095
- Citations
- 1
- Primary Topic
- Carcinogens and Genotoxicity Assessment
- Type
- article
- Field-Weighted Citation Impact
- 0.29
Funders
- National Cancer Institute